STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

IONS IONIS PHARMACEUTICALS INCORPORATED StockScouter® Report

6

StockScouter® Score

IONIS PHARMACEUTICALS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is above average. Positive/Neutral
  • The 50-day moving average for IONS is above its 200-day moving average. Positive

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • One or more analysts has significantly decreased quarterly earnings estimates for IONS. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 60% done.
Low
High

Core Model Grades

F
D
D
B

Previous Ratings

3
5
4